.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
UBS
Chubb
Colorcon
US Army
Queensland Health
Mallinckrodt
Federal Trade Commission
Fish and Richardson
Merck

Generated: June 22, 2017

DrugPatentWatch Database Preview

Naproxen - Generic Drug Details

« Back to Dashboard

What are the generic sources for naproxen and what is the scope of naproxen patent protection?

Naproxen
is the generic ingredient in eleven branded drugs marketed by Teva, Dava Pharms Inc, Invagen Pharms, Teva Pharms, Chartwell Molecules, Hamilton Pharms, Ivax Sub Teva Pharms, Roxane, Marksans Pharma, Zydus Pharms Usa, Mylan, Amneal Pharms Ny, Aurobindo Pharma Ltd, Actavis Elizabeth, Pliva, Perrigo R And D, Sandoz, Glenmark Generics, Watson Labs, Purepac Pharm, Watson Labs Teva, Atnahs Pharma Us, West-ward Pharms Int, Mylan Pharms Inc, Hikma Intl Pharms, Bayer, Glenmark Pharms Ltd, Actavis Labs Fl Inc, Bionpharma Inc, Contract Pharmacal, Able, Alvogen Malta, Granules India, Perrigo, Dr Reddys Labs Inc, Lnk Intl Inc, Hikma, Sun Pharm Inds Ltd, Dr Reddys Labs Ltd, and Pernix Ireland Ltd, and is included in seventy-two NDAs. There are six patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are forty-two drug master file entries for naproxen. Seventy suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for Generic Name: naproxen

Tradenames:11
Patents:6
Applicants:40
NDAs:72
Drug Master File Entries: see list42
Suppliers / Packagers: see list70
Bulk Api Vendors: see list76
Clinical Trials: see list242
Patent Applications: see list7,109
Therapeutic Class:Anti-inflammatory Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:naproxen at DailyMed

Pharmacology for Ingredient: naproxen

Tentative approvals for NAPROXEN

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe250MGTABLET;ORAL
► Subscribe► Subscribe500MGTABLET;ORAL
► Subscribe► Subscribe375MGTABLET;ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roxane
NAPROXEN
naproxen
TABLET;ORAL074211-001Feb 28, 1994DISCNNoNo► Subscribe► Subscribe
Teva
NAPROXEN SODIUM
naproxen sodium
TABLET;ORAL074142-002Dec 21, 1993DISCNNoNo► Subscribe► Subscribe
Teva Pharms
NAPROXEN SODIUM
naproxen sodium
TABLET;ORAL074289-002Jan 27, 1994DISCNNoNo► Subscribe► Subscribe
Teva Pharms
NAPROXEN
naproxen
TABLET;ORAL074207-001Dec 21, 1993DISCNNoNo► Subscribe► Subscribe
Teva
NAPROXEN SODIUM
naproxen sodium
TABLET;ORAL074142-001Dec 21, 1993DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: naproxen

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Atnahs Pharma Us
NAPROSYN
naproxen
SUSPENSION;ORAL018965-001Mar 23, 19874,009,197► Subscribe
Atnahs Pharma Us
NAPROSYN
naproxen
TABLET;ORAL017581-004Apr 15, 19824,001,301► Subscribe
Atnahs Pharma Us
NAPROSYN
naproxen
TABLET;ORAL017581-002Approved Prior to Jan 1, 19823,998,966► Subscribe
Atnahs Pharma Us
NAPROSYN
naproxen
TABLET;ORAL017581-002Approved Prior to Jan 1, 19824,001,301► Subscribe
Atnahs Pharma Us
NAPROSYN
naproxen
SUSPENSION;ORAL018965-001Mar 23, 19873,904,682► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Cerilliant
McKesson
Deloitte
Novartis
Queensland Health
Cantor Fitzgerald
Merck
Boehringer Ingelheim
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot